Tech Company Financing Transactions
BioFactura Funding Round
BioFactura closed a $1.8 million Series A funding round on 4/27/2016. Backers included private investors.
Transaction Overview
Company Name
Announced On
4/27/2016
Transaction Type
Venture Equity
Amount
$1,800,000
Round
Series A
Investors
Proceeds Purpose
The funds will be used to advance a portfolio of generic biologics, known as biosimilars, to the advanced preclinical stages.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8435 Progress Dr. Z
Frederick, MD 21701
USA
Frederick, MD 21701
USA
Phone
Website
Email Address
Overview
BioFactura develops and commercializes biodefense drugs, client-selected novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast Biomanufacturing Platform, the optimal choice for bringing these drugs to market with faster, lower cost, superior-quality manufacture
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Darryl Sampey
Chief Medical Officer
Jeffrey Hausfeld
Browse more venture capital transactions:
Prev: 4/27/2016: Immunio venture capital transaction
Next: 4/27/2016: R2 Semiconductor venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs